Chunlin Wang is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid amplification and sequencing. With a total of four patents to his name, Wang's work has advanced the efficiency and effectiveness of genetic analysis.

Latest Patents

Wang's latest patents include "Efficient methods and compositions for multiplex target amplification PCR." This patent discloses methods for enzymatic treatment of double-stranded PCR amplified products, aimed at minimizing primer-dimers in multiplex PCR reactions. It also enhances the efficiency of adapter ligation, allowing for more effective multiplex target amplification compared to conventional methods. Another significant patent is "Methods and compositions for enrichment of target nucleic acids," which relates to target enrichment and amplification of selective regions of genomes. This method is particularly useful for downstream procedures such as DNA sequencing and genetic variation detection.

Career Highlights

Throughout his career, Chunlin Wang has worked with various companies, including Chapter Diagnostics, Inc. and Irepertoire, Inc. His innovative approaches have contributed to advancements in genetic research and diagnostics.

Collaborations

Wang has collaborated with esteemed colleagues such as Zhihai Ma and Baback Gharizadeh. These partnerships have fostered a collaborative environment that promotes innovation and the development of cutting-edge technologies in the

This text is generated by artificial intelligence and may not be accurate.